Abiopharma

Vemanti Group, Inc. is a next-generation fintech holding company focused on accelerating financial innovation in Southeast Asia and beyond. We operate at the intersection of traditional finance and emerging digital asset technologies, with a core emphasis on cryptocurrency and blockchain-based platforms. Through strategic acquisitions, joint ventures, and investments in forward-thinking companies, were building a portfolio of high-impact digital financial services designed for growth and scalability. Our current focus is ONUS Pro, a licensed digital asset exchange delivering accessible, efficient, and compliant solutions to underserved markets. As a U.S. publicly traded company, our mission is to unlock long-term value for shareholders by leading the transition to a more inclusive and decentralized financial future.

Additional info from OTC:
Vemanti Group, Inc. is a next-generation fintech holding company focused on accelerating financial innovation in Southeast Asia and beyond. We operate at the intersection of traditional finance and emerging digital asset technologies, with a core emphasis on cryptocurrency and blockchain-based platforms. Through strategic acquisitions, joint ventures, and investments in forward-thinking companies, were building a portfolio of high-impact digital financial services designed for growth and scalability. Our current focus is ONUS Pro, a licensed digital asset exchange delivering accessible, efficient, and compliant solutions to underserved markets. As a U.S. publicly traded company, our mission is to unlock long-term value for shareholders by leading the transition to a more inclusive and decentralized financial future.